Black M, Da Silva P, Scott L. Rifampicin-resistant TB: discordance between Xpert(®) MTB/RIF and MTBDRplus results. Int J Tuberc Lung Dis. 2021;25(10):832-8.
Rifampicin-resistant TB: discordance between Xpert(®) MTB/RIF and MTBDRplus results
By Content Specialist|2022-06-14T18:15:00+02:00June 14, 2022|2021 Publication, 2021: October to December|Comments Off on Rifampicin-resistant TB: discordance between Xpert(®) MTB/RIF and MTBDRplus results
Share This Story, Choose Your Platform!
About the Author: Content Specialist
Related Posts
In Utero Human Cytomegalovirus Infection Is Associated With Increased Levels of Putatively Protective Maternal Antibodies in Nonprimary Infection: Evidence for Boosting but Not Protection